The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights From 2009

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 24, Issue 1, 2010, Pages 7-17

  Ramakrishna, Harish ^a   Fassl, Jens ^b   Sinha, Ashish ^c   Patel, Prakash ^c   Riha, Hynek ^d   Andritsos, Michael ^e   Chung, Insung ^c   Augoustides, John G T ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

anemia; angiotensin converting enzyme inhibitors; atrial natriuretic peptide; coronary artery bypass graft surgery; eltrombopag; endovascular saphenous vein graft harvesting; fenoldopam; hetastarch; hybrid operating room; intensive insulin therapy; intra aortic balloon counterpulsation; ischemic preconditioning; levosimendan; percutaneous coronary intervention; pharmacologic conditioning; prasugrel; romiplostim; sodium bicarbonate; ticagrelor; transcatheter aortic valve replacement; transcatheter mitral valve repair; volatile anesthetics

Indexed keywords

ACETYLCYSTEINE; ATRIAL NATRIURETIC FACTOR; BICARBONATE; BLOOD CLOTTING FACTOR 7; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELTROMBOPAG; ENDOTHELIN RECEPTOR ANTAGONIST; ERYTHROPOIETIN; FENOLDOPAM; HETASTARCH; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INHALATION ANESTHETIC AGENT; INSULIN; LEVOSIMENDAN; MILRINONE; PRASUGREL; ROMIPLOSTIM; STEROID; THIENOPYRIDINE DERIVATIVE; TICAGRELOR;

ANEMIA; ANESTHESIA; AORTA BALLOON; AORTA VALVE REPLACEMENT; BLEEDING; BLOOD TRANSFUSION; CARDIOVASCULAR SURGERY; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; GLYCEMIC CONTROL; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HEART SURGERY; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; HYBRID OPERATING ROOM; HYPOGLYCEMIA; INSULIN TREATMENT; KIDNEY DYSFUNCTION; OFF PUMP CORONARY SURGERY; OPERATING ROOM; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RENAL PROTECTION; REVIEW; SAPHENOUS VEIN; SURGICAL TECHNIQUE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTOPOIESIS; TRANSCATHETER AORTA VALVE REPLACEMENT; TREATMENT INDICATION; TREATMENT OUTCOME;

ANESTHESIOLOGY; ANESTHETICS, INHALATION; CATHETERIZATION; CORONARY ARTERY DISEASE; HEART DISEASES; HEMOSTASIS, SURGICAL; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; OPERATING ROOMS; THORACIC SURGERY;

EID: 74549145055     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2009.10.025     Document Type: Review

References (87)

1. Augoustides J.G. The year in cardiothoracic and vascular anesthesia: Selected highlights from 2008. J Cardiothorac Vasc Anesth 23 (2009) 1-7
2. Augoustides J.G., Wolfe Y., Walsh E.K., et al. Recent advances in aortic valve disease: Highlights from a bicuspid valve to transcatheter aortic valve replacement. J Cardiothorac Vasc Anesth 23 (2009) 569-576
3. Covello R.D., Maj G., Landoni G., et al. Anesthetic management of percutaneous aortic valve implantation: Focus on challenges encountered and proposed solutions. J Cardiothorac Vasc Anesth 23 (2009) 280-285
4. Fassl J., Walther T., Groesdonk H.V., et al. Anesthesia management for transapical transcatheter aortic valve implantation: A case series. J Cardiothorac Vasc Anesth 23 (2009) 286-291
5. Cook D.J., and Rehfeldt K.H. Catheter-based aortic valve replacement. J Cardiothorac Vasc Anesth 23 (2009) 277-279
6. Masson J.B., Kovac J., Schuler G., et al. Transcatheter aortic valve implantation: Review of the nature, management and avoidance of procedural complications. JACC Cardiovascular Interv 2 (2009) 811-820
7. Billings IV F.T., Kodali S.K., and Shanewise J.S. Transcatheter aortic valve implantation: Anesthetic considerations. Anesth Analg 108 (2009) 1453-1462
8. Fassl J., and Augoustides J.G. Transcatheter aortic valve replacement: Part 1-Development and status quo of the procedure. J Cardiothorac Vasc Anesth (2009 Nov 4) [Epub ahead of print]
9. Kovac J., Baron J.H., and Chin D.T. Are the standard criteria for TAVI too lax or too strict?. Heart (2009 Sep 23) [Epub ahead of print]
10. Dumont E., Lemieux J., Doyle D., et al. Feasibility of transapical aortic valve implantation fully guided by transesophageal echocardiography. J Thorac Cardiovasc Surg 138 (2009) 1022-1024
11. Ghaferi A.A., Birkmeyer J.D., and Dimick J.B. Variation in hospital mortality associated with inpatient surgery. N Engl J Med 361 (2009) 1368-1375
12. Byrne J.G., Leacche M., Vaughan D.E., et al. Hybrid cardiovascular procedures. JACC Cardiovasc Interv 1 (2008) 459-468
13. Nollert G., and Wich S. Planning a cardiovascular hybrid operating room: The technical point of view. Heart Surg Forum 12 (2009) E125-E130
14. Sawdy J.M., Gocha M.D., Olshove V., et al. Radiation protection during hybrid procedures: Innovation creates new challenges. J Invasive Cardiol 21 (2009) 437-440
15. Zhao D.X., Leacche M., Balaguer J.M., et al. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. J Am Coll Cardiol 53 (2009) 232-241
16. Wendt D., Eggebrecht H., Kahlert P., et al. Experience and learning curve with transapical aortic valve implantation. Herz 34 (2009) 388-397
17. Walther T., and Borger M.A. Valvular disease: Transcatheter aortic valve implantation - time for wider use. Nat Rev Cardiol 6 (2009) 618-619
18. Augoustides J.G., and Atluri P. Progress in mitral valve disease: Understanding the revolution. J Cardiothorac Vasc Anesth 23 (2009) 916-923
19. Rahimtoola S.H. The year in valvular heart disease. J Am Coll Cardiol 53 (2009) 1894-1908
20. Piazza N., Asgar A., Ibrahim R., et al. Transcatheter mitral and pulmonary valve therapy. J Am Coll Cardiol 53 (2009) 1837-1851
21. Cohen D.J. Cardiothoracic surgery at a crossroads: The impact of disruptive technologic change. J Cardiothorac Surg 2 (2007) 35
22. Iribarne A., Russo M.J., Moskowitz A.J., et al. Assessing technological change in cardiothoracic surgery. Semin Thorac Cardiovasc Surg 21 (2009) 28-34
23. Treasure T. Are randomized trials needed in the era of rapidly evolving technologies?. Eur J Cardiothorac Surg 35 (2009) 474-478
24. Venugopal V., Ludman A., Yellon D.M., et al. 'Conditioning' the heart during surgery. Eur J Cardiothorac Surg 35 (2009) 977-987
25. Pagel P.S. Cardioprotection by volatile anesthetics: Established scientific principle or lingering clinical uncertainty?. J Cardiothorac Vasc Anesth 23 (2009) 589-593
26. Landoni G., Bignami E., Oliviero F., et al. Halogenated anaesthetics and cardiac protection in cardiac and non-cardiac anaesthesia. Ann Card Anaesth 12 (2009) 4-9
27. Bignami E., Biondi-Zoccai G., Landoni G., et al. Volatile anesthetics reduce mortality in cardiac surgery. J Cardiothorac Vasc Anesth 23 (2009) 594-599
28. De Hert S.G., Lorsomradee S., van den Eede H., et al. A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction. J Cardiothorac Vasc Anesth 22 (2008) 699-705
29. Zangrillo A., Biondi-Zoccai G., Mizzi A., et al. Levosimendan reduces cardiac troponin release after cardiac surgery: A meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 23 (2009) 474-476
30. Landoni G., Mizzi A., Biondi-Zoccai G., et al. Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth (2009 Aug 21) [Epub ahead of print]
31. Walsh S.R., Tang T.Y., Kullar P., et al. Ischaemic preconditioning during cardiac surgery: Systematic review and meta-analysis of perioperative outcomes in randomized clinical trials. Eur J Cardiothorac Surg 34 (2009) 985-994
32. Takagi H., Manabe H., Kawai N., et al. Review and meta-analysis of randomized controlled clinical trials of remote ischemic preconditioning in cardiovascular surgery. Am J Cardiol 102 (2008) 1487-1488
33. Hoole S.P., Heck P.M., Sharples L., et al. Cardiac remote ischemic preconditioning in coronary stenting (CRISP Stent) study: A prospective randomized control trial. Circulation 119 (2009) 820-827
34. Kloner R.A. Clinical application of remote ischemic preconditioning. Circulation 119 (2009) 776-778
35. Venugopal V., Hausenloy D.J., Ludman A., et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: A randomized controlled trial. Heart 95 (2009) 1567-1571
36. Shimizu S., Tropak M., Diaz R.J., et al. Transient limb ischemia remotely preconditions through a humoral mechanism acting directly on the myocardium: Evidence suggesting cross-species protection. Clin Sci (Lond) 117 (2009) 191-200
37. Kheterpal S., Khodaparast O., Shanks A., et al. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. J Cardiothorac Vasc Anesth 22 (2008) 180-186
38. Augoustides J.G.T. Angiotensin blockade and general anesthesia: So little known, so far to go. J Cardiothorac Vasc Anesth 22 (2008) 177-179
39. Miceli A., Capoun R., Fino C., et al. Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 54 (2009) 1778-1884
40. Augoustides J.G. Should all antihypertensive agents be continued before surgery?. In: Fleisher L.A. (Ed). Evidence-Based Practice of Anesthesiology (2009), Elsevier, Philadelphia, PA 49-54
41. Shahzamani M., Yousefi Z., Frootaghe A.N., et al. The effect of angiotensin-converting enzyme inhibitor on hemodynamic instability in patients undergoing cardiopulmonary bypass: Results of a dose-comparison study. J Cardiovasc Pharmacol Ther 14 (2009) 185-191
42. Augoustides J.G.T., and Patel P. Recent advances in perioperative medicine: Highlights from the literature for the cardiothoracic and vascular anesthesiologist. J Cardiothorac Vasc Anesth 23 (2009) 430-436
43. van Straten A.H.M., Hamad M.A.S., van Zundert A.J., et al. Preoperative hemoglobin level as a predictor of survival after coronary artery bypass grafting: A comparison with the matched general population. Circulation 120 (2009) 118-125
44. van Straten A.H., Hamad M.A.S., van Zundert A.A., et al. Risk factors for deterioration of renal function after coronary artery bypass grafting. Eur J Cardiothorac Surg (2009 Aug 19) [Epub ahead of print]
45. Lopes R.D., Hafley G.E., Allen K.B., et al. Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. New Engl J Med 361 (2009) 235-244
46. Scott B.H., Seifert F.C., Grimson R., et al. Resource utilization and off-pump coronary artery surgery; factors influencing postoperative length of stay-An experience of 1,746 consecutive patients undergoing fast-track cardiac anesthesia. J Cardiothorac Vasc Anesth 19 (2005) 26-31
47. Chu D., Bakaeen F.G., Dao T.K., et al. On-pump versus off-pump coronary artery bypass grafting in a cohort of 63,000 patients. Ann Thorac Surg 87 (2009) 1820-1827
48. Puskas J.D., Thourani V.H., Kilgo P., et al. Off-pump coronary artery bypass disproportionately benefits high-risk patients. Ann Thorac Surg 88 (2009) 1142-1147
49. Shroyer A.L., Coombs L.P., Peterson E.D., et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 75 (2003) 1856-1865
50. Verheught F.W.A. Reperfusion therapy for ST-segment elevation myocardial infarction: Trials, registries, and guidelines. Circulation 119 (2009) 3047-3049
51. Huynh T., Perron S., O'Loughlin J., et al. Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: Bayesian hierarchial meta-analyses of randomized controlled trials and observational studies. Circulation 119 (2009) 3101-3109
52. Cantor W.J., Fitchett D., Borgundvaag B., et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med 360 (2009) 2705-2718
53. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110 (2004) e82-e292
54. Sjauw K.D., Engstrom A.E., Vis M.M., et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: Should we change the guidelines?. Eur Heart J 30 (2009) 459-468
55. van Werkum J.W., Heestermans A.A.C.M., de Korte F.I., et al. Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: An analysis of 431 cases. Circulation 119 (2009) 828-834
56. Pena A., Collet J.P., Hulot J.B., et al. Can we override clopidogrel resistance?. Circulation 119 (2009) 2854-2857
57. Wiviott S.D., Trenk D., Frelinger A.L., et al. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation 116 (2007) 2923-2932
58. Wiviott S.D., Braunwald E., McCabe C.H., et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357 (2007) 2001-2015
59. Montalescot G., Wiviott S.D., Braunwald E., et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): A double-blind, randomized controlled trial. Lancet 373 (2009) 723-731
60. Bhatt D.L. Prasugrel in clinical practice. N Engl J Med 361 (2009) 940-942
61. 12 inhibitors: Differences in properties and mechanisms of action and potential consequences for clinical use. Eur Heart J 30 (2009) 1964-1977
62. Wallentin L., Becker R.C., Budaj A., et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361 (2009) 1045-1057
63. Augoustides J.G.T., and Ramakrishna H. Recent advances in the management of coronary artery disease: Highlights from the literature. J Cardiothorac Vasc Anesth 23 (2009) 259-265
64. Blackledge H.M., and Squire I.B. Improving long-term outcomes following coronary artery bypass graft or percutaneous coronary revascularization: Results from a large population-based cohort with first intervention 1995-2004. Heart 95 (2009) 304-311
65. Li Y., Zheng Z., Xu B., et al. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: Three year follow-up results from a single institution. Circulation 119 (2009) 2040-2050
66. Hlatky M.A., Boothroyd D.R., Bravata D.M., et al. Coronary artery bypass surgery compared with percutaneous coronary intervention for multivessel disease: A collaborative analysis of individual patient data from 10 randomised trials. Lancet 373 (2009) 1190-1197
67. Christensen M.C., Krapf S., Kempel A., et al. Costs of excessive postoperative hemorrhage in cardiac surgery. J Thorac Cardiovasc Surg 138 (2009) 687-693
68. Weightman W.M., Gibbs N.M., Sheminant M.R., et al. Moderate exposure to allogeneic blood products is not associated with reduced long-term survival after surgery for coronary artery disease. Anesthesiology 111 (2009) 327-333
69. Augoustides J.G. Is there a best technique to decrease blood loss and transfusion after coronary artery bypass grafting?. In: Fleisher L.A. (Ed). Evidence-Based Practice of Anesthesiology (2009), Elsevier, Philadelphia, PA 415-423
70. Hecht-Dolnik M., Barkan H., Taharka A., et al. Hetastarch increases the risk of bleeding complications in patients after off-pump coronary artery bypass surgery: A randomized clinical trial. J Thorac Cardiovasc Surg 138 (2009) 703-711
71. Wijeysundera D.N., Karkouti K., Rao V., et al. N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery. Crit Care Med 37 (2009) 1929-1934
72. Zangrillo A., Mizzi A., Biondi-Zoccai G., et al. Recombinant activated factor VII in cardiac surgery: A meta-analysis. J Cardiothorac Vasc Anesth 23 (2009) 34-40
73. Gill R., Herbertson M., Vuylsteke A., et al. Safety and efficacy of recombinant activated factor VII: A randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 120 (2009) 21-27
74. Nurden A.T., Viallard J.F., and Nurden P. New generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura. Lancet 373 (2009) 1562-1569
75. Najafi M., Goodarzynejad H., Karimi A., et al. Is preoperative serum creatinine a reliable indicator of outcome in patients undergoing coronary artery bypass surgery?. J Thorac Cardiovasc Surg 137 (2009) 304-308
76. Roasio A., Lobreglio R., Santin A., et al. Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery. J Cardiothorac Vasc Anesth 22 (2009) 23-26
77. Morikawa S., Sone T., Tsuboi H., et al. Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide. J Am Coll Cardiol 53 (2009) 1040-1046
78. Sezai A., Hata M., Niino T., et al. Influence of continuous infusion of low-dose human atrial natriuretic peptide on renal function during cardiac surgery: A randomized controlled study. J Am Coll Cardiol 54 (2009) 1058-1064
79. Haase M., Haase-Fielitz A., Bellomo R., et al. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: A pilot double-blind, randomized controlled trial. Crit Care Med 37 (2009) 39-47
80. Rioux J.P., Lessard M., De Bortoli B., et al. Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med 37 (2009) 1293-1298
81. Ferrario F., Barone M.T., Landoni G., et al. Acetylcysteine and non-ionic isoosmolar contrast-induced nephropathy-A randomized controlled study. Nephrol Dial Transplant 24 (2009) 3103-3107
82. Bochicchio G.V., and Scalea T.M. Glycemic control in the ICU. Adv Surg 42 (2008) 261-275
83. The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360 (2009) 1283-1297
84. Kosiborod M., Inzucchi S.E., Krumholz H.M., et al. Glucometrics in patients hospitalized with acute myocardial infarction: Defining the optimal outcomes-based measure of risk. Circulation 117 (2008) 1018-1027
85. Kosiborod M., Inzucchi S.E., Goyal A., et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 301 (2009) 1556-1564
86. Griesdale D.E.G., de Souza R.J., and van Dam R.M. Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data. CMAJ 180 (2009) 821-827
87. Lazar H.L., McDonnell M., Chipkin S.R., et al. The Society of Thoracic Surgeons practice guideline series: Blood glucose management during adult cardiac surgery. Ann Thorac Surg 87 (2009) 663-669